Lv4
668 积分 2022-10-25 加入
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
2个月前
已完结
Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE®) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation Study
3个月前
已完结
Survey Outcome on Immunogenicity Risk Assessment Tools for Biotherapeutics: an Insight into Consensus on Methods, Application, and Utility in Drug Development
3个月前
已完结
Gold nanoparticles-decorated M13 phage SPR probe for dual detection of antigen biomarkers in serum
3个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
3个月前
已完结
Investigation of Immune Responses to Oxidation, Deamidation, And Isomerization in Therapeutic Antibodies using Preclinical Immunogenicity Risk Assessment Assays
3个月前
已完结
人工饲养条件下恒河猴血液学、血液生化正常参考值测定及分析
4个月前
已完结
恒河猴血液细胞、生化和凝血功能正常参考指标的测定
4个月前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
4个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
4个月前
已完结
皖公网安备34019202002308
